Cadwalader’s Role in $68bn Pfizer’s Acquisition

by Edwin Rosenthal

The acquisition of Wyeth by its rival and drug manufacturer of US – Pfizer has made big news in the industry. The deal which costs around $68bn (£49.8bn) was announced by the board of Pfizer, on 26th January 2009.

The Cadwalader Wickersham & Taft played a major role in the entire acquisition plan and process. The transaction would be the biggest merger since the $70 billion deal signed by the AT&T and BellSouth, in March 2006.

Wyeth was taking support from a team from Simpson Thacher & Bartlett and corporate partner Eric Swedenburg, led by global head of M&A Casey – Cogut. The board of directors of Wyeth was also into taking legal advices from Wachtell Lipton Rosen & Katz.

Cadwalader is offering its legal services since 1792, and has many big names in its clients list. If the acquisition works out, it would be one of the historic events for Cadwalader.


Comments are closed.